You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

URECHOLINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Urecholine, and when can generic versions of Urecholine launch?

Urecholine is a drug marketed by Odyssey Pharms and is included in five NDAs.

The generic ingredient in URECHOLINE is bethanechol chloride. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Urecholine

A generic version of URECHOLINE was approved as bethanechol chloride by UPSHER SMITH LABS on June 1st, 2005.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for URECHOLINE?
  • What are the global sales for URECHOLINE?
  • What is Average Wholesale Price for URECHOLINE?
Summary for URECHOLINE
Drug patent expirations by year for URECHOLINE
Recent Clinical Trials for URECHOLINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Augusta UniversityPhase 1

See all URECHOLINE clinical trials

US Patents and Regulatory Information for URECHOLINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Odyssey Pharms URECHOLINE bethanechol chloride INJECTABLE;INJECTION 006536-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Odyssey Pharms URECHOLINE bethanechol chloride TABLET;ORAL 006536-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Odyssey Pharms URECHOLINE bethanechol chloride TABLET;ORAL 088440-001 May 29, 1984 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Odyssey Pharms URECHOLINE bethanechol chloride TABLET;ORAL 089096-001 Dec 19, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Odyssey Pharms URECHOLINE bethanechol chloride TABLET;ORAL 089095-001 Dec 19, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.